<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_KwSGG9J">Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease A Meta-analysis</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
					<p type="raw">Copyright 2016 American Medical Association. All rights reserved. Copyright 2016 American Medical Association. All rights reserved. Downloaded from jamanetwork.com by University of Iowa user on 07/11/2025 Copyright 2016 American Medical Association. All rights reserved. Copyright 2016 American Medical Association. All rights reserved. Downloaded from jamanetwork.com by University of Iowa user on 07/11/2025 Copyright 2016 American Medical Association. All rights reserved. ditional arms and treated this group as a non-text message intervention arm. For trials reporting multiple follow-ups, the final follow-up corresponding to the study duration was used. Copyright 2016 American Medical Association. All rights reserved. Downloaded from jamanetwork.com by University of Iowa user on 07/11/2025 Copyright 2016 American Medical Association. All rights reserved. Copyright 2016 American Medical Association. All rights reserved. Downloaded from jamanetwork.com by University of Iowa user on 07/11/2025 Copyright 2016 American Medical Association. All rights reserved.</p>
				</availability>
				<date type="published" when="2016-02-01">February 1, 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>FRACP</roleName><forename type="first">Jay</forename><surname>Thakkar</surname></persName>
							<email>jthakkar@georgeinstitute.org.au</email>
						</author>
						<author>
							<persName><roleName>MBBS</roleName><forename type="first">Rahul</forename><surname>Kurup</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Tracey-Lea</forename><surname>Laba</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Karla</forename><surname>Santo</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Aravinda</forename><surname>Thiagalingam</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Anthony</forename><surname>Rodgers</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Mark</forename><surname>Woodward</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Julie</forename><surname>Redfern</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Clara</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
						</author>
						<author>
							<persName><surname>Thakkar</surname></persName>
						</author>
						<author>
							<persName><surname>Kurup</surname></persName>
						</author>
						<author>
							<persName><surname>Laba</surname></persName>
						</author>
						<author>
							<persName><roleName>Rodgers, Woodward, Redfern</roleName><surname>Santo</surname></persName>
						</author>
						<author>
							<persName><roleName>Thiagalingam, Rodgers, Woodward, Redfern</roleName><forename type="first">Santo</forename><surname>Laba</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<note type="raw_affiliation">Department of Cardiology , Westmead Hospital , Sydney , Australia</note>
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Westmead Hospital</orgName>
								<address>
									<settlement>Sydney</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<note type="raw_affiliation">Thiagalingam , Chow ); The George Institute for Global Health ,</note>
								<orgName type="department">The George Institute for Global Health</orgName>
								<orgName type="institution">Thiagalingam</orgName>
								<address>
									<settlement>Chow</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<note type="raw_affiliation">The University of Sydney , Sydney , Australia Chow) ;</note>
								<orgName type="department">Chow)</orgName>
								<orgName type="institution">The University of Sydney</orgName>
								<address>
									<settlement>Sydney</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<note type="raw_affiliation">The University of Sydney , Sydney , Australia Chow) ;</note>
								<orgName type="department">Chow)</orgName>
								<orgName type="institution">The University of Sydney</orgName>
								<address>
									<settlement>Sydney</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<note type="raw_affiliation">The George Institute for Global Health , University of Oxford , Oxford , England ( Woodward) ; Department of Epidemiology ,</note>
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="laboratory">Woodward)</orgName>
								<orgName type="institution" key="instit1">The George Institute for Global Health</orgName>
								<orgName type="institution" key="instit2">University of Oxford</orgName>
								<address>
									<settlement>Oxford</settlement>
									<country key="GB">England</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<note type="raw_affiliation">Johns Hopkins Blumberg School of Public Health , Baltimore , Maryland (Woodward). The George Institute for Global Health ,</note>
								<orgName type="department">The George Institute for Global Health</orgName>
								<orgName type="institution">Johns Hopkins Blumberg School of Public Health</orgName>
								<address>
									<settlement>Baltimore</settlement>
									<region>Maryland (Woodward</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<note type="raw_affiliation">The University of Sydney , Missenden Road , PO Box M 201 , Level 10 , King George V Bldg , Camperdown , New South Wales , Australia 2050</note>
								<orgName type="institution">The University of Sydney</orgName>
								<address>
									<addrLine>Missenden Road Level 10 King George V Bldg</addrLine>
									<postBox>PO Box M 201</postBox>
									<postCode>2050</postCode>
									<settlement>Camperdown</settlement>
									<region>New South Wales</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_be2RjZ8">Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease A Meta-analysis</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-02-01">February 1, 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">0D65F9C66F451EE61CC6CA15B8EF0029</idno>
					<idno type="DOI">10.1001/jamainternmed.2015.7667</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T10:35+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_d2ZJVT4"><p xml:id="_fDtkmZB"><s xml:id="_gQ7YbP7">IMPORTANCE Adherence to long-term therapies in chronic disease is poor.</s><s xml:id="_A9aYMxB">Traditional interventions to improve adherence are complex and not widely effective.</s><s xml:id="_xgePmgD">Mobile telephone text messaging may be a scalable means to support medication adherence.</s></p><p xml:id="_9ACZ9uN"><s xml:id="_REzdjP3">OBJECTIVES To conduct a meta-analysis of randomized clinical trials to assess the effect of mobile telephone text messaging on medication adherence in chronic disease.</s><s xml:id="_ppWktaZ">DATA SOURCES MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, PsycINFO, and CINAHL (from database inception to January 15, 2015), as well as reference lists of the articles identified.</s><s xml:id="_ZE4KpZn">The data were analyzed in March 2015.</s><s xml:id="_S2dPBUz">STUDY SELECTION Randomized clinical trials evaluating a mobile telephone text message intervention to promote medication adherence in adults with chronic disease.</s></p><p xml:id="_UyaUvgr"><s xml:id="_KPNv9TP">DATA EXTRACTION Two authors independently extracted information on study characteristics, text message characteristics, and outcome measures as per the predefined protocol.</s></p><p xml:id="_RNjSka4"><s xml:id="_yubM9kt">MAIN OUTCOMES AND MEASURES Odds ratios and pooled data were calculated using random-effects models.</s><s xml:id="_Ev4UM3S">Risk of bias and study quality were assessed as per Cochrane guidelines.</s><s xml:id="_pktRCAY">Disagreement was resolved by consensus.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Enx96xR">RESULTS</head><p xml:id="_awN6psn"><s xml:id="_J4Uc59h">Sixteen randomized clinical trials were included, with 5 of 16 using personalization, 8 of 16 using 2-way communication, and 8 of 16 using a daily text message frequency.</s><s xml:id="_U52wdwg">The median intervention duration was 12 weeks, and self-report was the most commonly used method to assess medication adherence.</s><s xml:id="_JUXjBGS">In the pooled analysis of 2742 patients (median age, 39 years and 50.3% [1380 of 2742] female), text messaging significantly improved medication adherence (odds ratio, 2.11; 95% CI, 1.52-2.93;</s><s xml:id="_xy2mr7y">P &lt; .001).</s><s xml:id="_qRtxGS6">The effect was not sensitive to study characteristics (intervention duration or type of disease) or text message characteristics (personalization, 2-way communication, or daily text message frequency).</s><s xml:id="_cjYZEyc">In a sensitivity analysis, our findings remained robust to change in inclusion criteria based on study quality (odds ratio, 1.67; 95% CI, 1.21-2.29;</s><s xml:id="_KS3ab8z">P = .002).</s><s xml:id="_w8NSdDx">There was moderate heterogeneity (I 2 = 62%) across clinical trials.</s><s xml:id="_sBKDY56">After adjustment for publication bias, the point estimate was reduced but remained positive for an intervention effect (odds ratio, 1.68; 95% CI, 1.18-2.39).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_vtM2My5">CONCLUSIONS AND RELEVANCE</head><p xml:id="_5h3fBG5"><s xml:id="_GUdA3rq">Mobile phone text messaging approximately doubles the odds of medication adherence.</s><s xml:id="_pvTMMtB">This increase translates into adherence rates improving from 50% (assuming this baseline rate in patients with chronic disease) to 67.8%, or an absolute increase of 17.8%.</s><s xml:id="_QCVSn3A">While promising, these results should be interpreted with caution given the short duration of trials and reliance on self-reported medication adherence measures.</s><s xml:id="_qXmCGBB">Future studies need to determine the features of text message interventions that improve success, as well as appropriate patient populations, sustained effects, and influences on clinical outcomes.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_Xn4ZtRw"><p xml:id="_JFstnTP"><s xml:id="_natBpr8">A dherence is defined as the extent to which a patient correctly follows a prescribed therapy.</s><s xml:id="_rnVNxwy">Adherence is the medically preferred term because it reflects active involvement of the patient and a therapeutic alliance between the patient and his or her physician. <ref type="bibr" target="#b0">1</ref></s><s xml:id="_THyVwUu">This term is in contrast to compliance, which reflects more unidirectional connotations. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b1">2</ref></s><s xml:id="_DmEt6Ae">Adherence to long-term therapies in developed countries is typically reported to be approximately 50% at 1 year after initiation of therapy, with worse rates in lower socioeconomic groups and in developing countries. <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b3">4</ref></s><s xml:id="_V3fNHqH">Poor adherence has been linked to successive hospitalizations, increased need for medical interventions, morbidity, and mortality. <ref type="bibr" target="#b4">5</ref></s><s xml:id="_dc9PK68">In addition, medication nonadherence results in increased health care cost, with estimates from North America of approximately $100 billion being spent annually and $2000 spent per patient per year in excess physician visits. <ref type="bibr" target="#b5">6</ref></s><s xml:id="_b4R2W6c">nterventions that improve adherence may have far greater effect on the health of a population than any improvement in specific medical treatment. <ref type="bibr" target="#b6">7</ref></s><s xml:id="_qmATWqN">A review article by Haynes et al <ref type="bibr" target="#b7">8</ref> concluded that almost all interventions that were effective for long-term care were complex and not widely effective.</s><s xml:id="_CkxWDh5">There is widespread need for convenient and feasible innovations to help patients remain adherent to medications. <ref type="bibr" target="#b8">9</ref></s><s xml:id="_VTCq75W">In recent years, mobile health (mHealth) has emerged as a strategy to improve the implementation of evidence-based medicine and support public health by using mobile digital devices. <ref type="bibr" target="#b9">10</ref></s><s xml:id="_2VQay9a">The usefulness of this medium has been explored to improve treatment adherence.</s><s xml:id="_gewTP4V">Electronic reminders can be delivered in various forms.</s><s xml:id="_VV5D74B">The use of mobile apps (software applications) requires specialized devices (smartphones, tablet computers, or personal digital assistants). <ref type="bibr" target="#b10">11</ref></s><s xml:id="_6uMvmeW">Other media for reminders are pagers or dedicated devices for audiovisual reminders.</s><s xml:id="_5bBpkvp">However, their availability within usual health care is low and presents a challenge for translation into routine clinical practice.</s></p><p xml:id="_GWvvBpg"><s xml:id="_adGEHeF">Mobile telephone text messaging may be a more feasible platform to deliver electronic reminders in practice.</s><s xml:id="_tpbQgq8">The technology is old and therefore can be delivered to any existing mobile telephone.</s><s xml:id="_VWK2edT">Subscription to mobile telephones is ever increasing.</s><s xml:id="_t8cp3Xk">According to one estimate, there were approximately 7 billion mobile subscribers by the end of 2014, roughly corresponding to the global population. <ref type="bibr" target="#b11">12</ref></s><s xml:id="_sShCGGg">This technology is increasingly used by people from all socioeconomic classes, <ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b13">14</ref> age groups, <ref type="bibr" target="#b12">13</ref> and continents. <ref type="bibr" target="#b14">15</ref></s><s xml:id="_jQDFjNT">n recent times, text messages have been widely used as a reminder and support in various health programs.</s><s xml:id="_RxmAahj">While previous reviews have shown favorable effects of text messaging, only narrative reviews of text messages without meta-analysis <ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b16">17</ref> and a meta-analysis <ref type="bibr" target="#b17">18</ref> that included a diverse range of electronic interventions (text messages, audiovisual reminders, pagers, and beepers) have been published to date.</s><s xml:id="_zGzMbds">The aim of this review was to estimate the effect of text messaging on medication adherence in adults with chronic medical disorders.</s><s xml:id="_xPvRkTq">Secondary aims were to describe and examine the effect of characteristics of text message interventions, including frequency of messaging, interactivity, and customization, and to describe perceptions and acceptability to participants.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_DzVzf3H">Methods</head><p xml:id="_Fbvd3bv"><s xml:id="_vN86SYs">This review was written and detailed in accord with the Preferred Reporting Items for Systematic Reviews and Meta-analyses statement and the Cochrane Collaboration reporting items for systematic reviews and meta-analyses. <ref type="bibr" target="#b18">19</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_s6YEze8">Literature Search</head><p xml:id="_YAxXX9F"><s xml:id="_75Br32h">A computerized literature search of MEDLINE, EMBASE, CINAHL, PsycINFO, Cochrane Central Register of Controlled Trials, and trial registries (clinicaltrials.gov</s><s xml:id="_zYPyCUR">and ANZCTR [<ref type="url" target="http://www.anzctr.org.au/">http:  //www.anzctr.org.au/</ref>]) was conducted using Medical Subject Headings and keywords.</s><s xml:id="_dV8jHGs">The keywords included (1) intervention (text messaging, text messages, short message service, mobile phone, and cellular phone) and (2) medication use (adherence, nonadherence, compliance, noncompliance, refuse, refusal, treatment refusal, and patient compliance).</s><s xml:id="_sHFeJqy">No restriction on publication date was applied.</s><s xml:id="_j5YYyfZ">The electronic database was last searched on January 15, 2015.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_x62knqz">Study Eligibility</head><p xml:id="_MTjsgv8"><s xml:id="_r6avRRz">We included trials based on the following criteria: (1) the trial studied adult patients (≥18 years) with chronic disease, (2) the patients received a mobile telephone text message intervention designed to promote medication adherence, (3) the design was a randomized clinical trial (RCT) with at least 4 weeks' followup, and (4) the trial reported quantitative measures of the effect of text messaging on medication adherence.</s><s xml:id="_kYfZTx5">We excluded studies based on the following criteria: (1) the primary intervention under consideration was not limited to text messages, (2) the focus was solely disease management or education and did not report medication adherence or reported only surrogate outcomes (eg, CD4 cell count or glycated hemoglobin level), and (3) the study involved psychiatric, military, or institutionalized patients.</s><s xml:id="_vzFH4uR">The latter criterion was to avoid the potential influence of psychosocial or institutional controls on adherence.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_dDusPUf">Data Extraction</head><p xml:id="_AFUv77X"><s xml:id="_9xM8EHj">Two of us (J.T. and R.K.) independently screened all identified titles and abstracts from the literature search using a predefined protocol.</s><s xml:id="_rynbHvC">We reviewed reference lists of relevant articles for additional publications.</s><s xml:id="_Z2nwQXE">Full texts of screened articles were reviewed for inclusion criteria and study quality.</s><s xml:id="_9MF9EEH">Disagreements were resolved through discussion or in consultation with a third independent reviewer (C.K.C.).</s><s xml:id="_54f2zt7">If more than 1 publication of an original trial was identified, such articles were assessed together to maximize data collection.</s><s xml:id="_kxfmstq">We extracted data on study characteristics, text message characteristics, and outcomes.</s><s xml:id="_r7RV5u9">We used the Cochrane Handbook for Systematic Reviews of Interventions <ref type="bibr" target="#b19">20</ref> guidelines for trials with multiple intervention arms.</s><s xml:id="_fHjvS39">When reported, we used the overall intervention effect.</s><s xml:id="_XBQ3Wk4">Otherwise, we combined trial arms (ie, text message vs non-text message arms).</s><s xml:id="_J62fVsa">We did not follow the alternative strategy of selecting a single pair of interventions because that can result in loss of information and introduce bias if the arm with positive results is preferentially included for analysis.</s><s xml:id="_CHYEnWa">For example, for the trial by Lv et al, <ref type="bibr" target="#b20">21</ref> we combined control and tra-</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_8e9FUvh">Assessment of Study Quality</head><p xml:id="_xFZZS2g"><s xml:id="_RA396Za">Two of us (J.T. and R.K.) independently assessed the risk of bias of included studies, with any disagreements resolved by discussion and a third opinion (C.K.C.) to reach consensus.</s><s xml:id="_fQWTMm8">We assessed the methodological risk of bias of included studies in accord with the Cochrane Handbook for Systematic Reviews of Interventions, <ref type="bibr" target="#b18">19</ref> which recommends reporting of the following individual elements for RCTs: random sequence generation, randomization sequence concealment, masking, completeness of outcome data, selective outcome reporting, and other sources of bias.</s><s xml:id="_8QyruPS">Each item is judged as being at high, low, or unclear risk of bias.</s><s xml:id="_FVujfsu">Studies were deemed to be at highest risk of bias if they were scored as being at high or unclear risk of bias for the sequence generation or randomization concealment domains.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_fhKDSQf">Statistical Analysis</head><p xml:id="_qsq3ZxC"><s xml:id="_VBSQfCC">We used a software program (Comprehensive Meta-analysis, version 2.2.064;</s><s xml:id="_mGrrw7z">Biostat) for statistical analyses. <ref type="bibr" target="#b21">22</ref></s><s xml:id="_uC3NmK8">We used the mean effect size approach to pool estimates, which has been used by others. <ref type="bibr" target="#b17">18</ref></s><s xml:id="_pFGdfYF">The effect size was weighted as per the study sample size.</s><s xml:id="_Bpj4ZRF">We used individual patient data when available.</s><s xml:id="_PrbXcmy">If only aggregate data were available, we used estimates of treatment difference and their variance. <ref type="bibr" target="#b22">23</ref></s><s xml:id="_QWSQ9Gx">We calculated the odds ratio (OR) for each primary study and used random-effects models to pool estimates.</s><s xml:id="_GFPCWP5">We also calculated Cohen d as a magnitude of the effect size.</s><s xml:id="_Xe39b9Z">Cohen d values of 0.2, 0.5, and 0.8 are generally considered as small, medium, and large effect sizes, respectively. <ref type="bibr" target="#b23">24</ref></s><s xml:id="_snqyB6J">e used the I 2 statistic to assess heterogeneity.</s><s xml:id="_XWmdvW6">An I 2 statistic exceeding 50% with P &lt; .05 was interpreted as representing substantial heterogeneity. <ref type="bibr" target="#b24">25</ref></s><s xml:id="_UNFXEJD">We assessed publication bias using funnel plot symmetry and Egger regression intercept.</s><s xml:id="_Zk8uvdq">If publication bias exists, the funnel plot is asymmetric, with Egger test P &lt; .05.</s><s xml:id="_ssDwH9r">We used the trim-and-fill method by Duval and Tweedie <ref type="bibr" target="#b25">26</ref> to impute the missing studies.</s><s xml:id="_QEesPMw">We performed subgroup analysis based on study and text message characteristics.</s></p><p xml:id="_CDfTbhn"><s xml:id="_rfreutV">There are no clear guidelines or criterion standard recommendations on how to assess medication adherence or define adherence outcomes. <ref type="bibr" target="#b26">27,</ref><ref type="bibr">28</ref></s><s xml:id="_H7zzChb">Our primary analysis was to examine the effects of text message interventions on medication adherence.</s><s xml:id="_H2nQGaZ">We defined adherent patients as those individuals determined to be adherent as defined by the individual included trials.</s><s xml:id="_hNyWgNT">For trials that reported multiple measures of adherence, we selected the most objective measure of adherence according to a predefined hierarchy (ie, electronic monitoring over pill count over self-recall, as well as a continuous scale over a dichotomized scale. <ref type="bibr" target="#b17">18</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_kNZDgrc">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_CgjzMJ4">Study Characteristics</head><p xml:id="_EuNP3Tr"><s xml:id="_7rEfumF">We assessed 44 full-text articles for eligibility and identified 16 RCTs <ref type="bibr" target="#b20">21,</ref><ref type="bibr">[29]</ref><ref type="bibr">[30]</ref><ref type="bibr">[31]</ref><ref type="bibr">[32]</ref><ref type="bibr">[33]</ref><ref type="bibr">[34]</ref><ref type="bibr">[35]</ref><ref type="bibr">[36]</ref><ref type="bibr">[37]</ref><ref type="bibr">[38]</ref><ref type="bibr">[39]</ref><ref type="bibr">[40]</ref><ref type="bibr">[41]</ref><ref type="bibr">[42]</ref><ref type="bibr">[43]</ref> (Figure <ref type="figure">1</ref>, Table <ref type="table" target="#tab_2">1</ref>, and eTable 1 in the Supplement) involving 2742 patients that met our inclusion criteria.</s></p><p xml:id="_mKaQ3rs"><s xml:id="_knH9VvS">The median sample size was 97 (range, 21-538).</s><s xml:id="_vE8pvDS">The median age of participants was 39 years (age range, 31-64 years), and 50.3% (1380 of 2742) were female.</s><s xml:id="_HDgHbhA">The studies evaluated various chronic diseases, including human immunodeficiency virus (HIV) infection, <ref type="bibr">29,</ref><ref type="bibr">30,</ref><ref type="bibr">32,</ref><ref type="bibr">34,</ref><ref type="bibr">35,</ref><ref type="bibr">37</ref> cardiovascular disease (CVD), <ref type="bibr">31,</ref><ref type="bibr">36,</ref><ref type="bibr">38,</ref><ref type="bibr">41,</ref><ref type="bibr">43</ref> asthma, <ref type="bibr" target="#b20">21,</ref><ref type="bibr">39</ref> allergic rhinitis, 42 diabetes mellitus, <ref type="bibr">40</ref> and epilepsy. <ref type="bibr">33</ref></s><s xml:id="_vhjxpEB">The median intervention duration was 12 weeks (range, 4-48 weeks).</s></p><p xml:id="_QuYQNN8"><s xml:id="_8f49Ahj">Self-recall was the most commonly used method to assess adherence, <ref type="bibr" target="#b20">21,</ref><ref type="bibr">[31]</ref><ref type="bibr">[32]</ref><ref type="bibr">[33]</ref><ref type="bibr">[34]</ref><ref type="bibr">36,</ref><ref type="bibr">38,</ref><ref type="bibr">41,</ref><ref type="bibr">42</ref> followed by medication event monitoring system 29,30,36,37 and pill count. <ref type="bibr">29,</ref><ref type="bibr">30,</ref><ref type="bibr">43</ref></s><s xml:id="_Fx9cP68">Adherence outcome data were reported in 12 studies <ref type="bibr" target="#b20">21,</ref><ref type="bibr">29,</ref><ref type="bibr">[31]</ref><ref type="bibr">[32]</ref><ref type="bibr">[33]</ref><ref type="bibr">[34]</ref><ref type="bibr">[35]</ref><ref type="bibr">37,</ref><ref type="bibr">38,</ref><ref type="bibr">[41]</ref><ref type="bibr">[42]</ref><ref type="bibr">[43]</ref> as proportion of patients adherent and in 4 studies <ref type="bibr">30,</ref><ref type="bibr">36,</ref><ref type="bibr">39,</ref><ref type="bibr">40</ref> as proportion of medication doses taken as prescribed.</s><s xml:id="_7Nz8Ad7">The adherence cutoff was defined at 95% in 6 HIV trials and 1 CVD trial, at 90% in 1 HIV trial, at 80% in 1 CVD trial, and at 80% in one hypertension trial. The control</s><s xml:id="_S7cjx2S">arm in 15 studies was standard therapy. Only 1 s</s><s xml:id="_7sHRqJN">udy 30 compared the text message intervention with a control arm (using additional 1-way pager or beeper).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_MRTEQBN">Text Message Characteristics</head><p xml:id="_Se7bpK5"><s xml:id="_g5WUvd4">There was considerable variation in the text message intervention characteristics (Table <ref type="table" target="#tab_3">2</ref>).</s><s xml:id="_FcpdH2w">Fifteen studies sent text messages at a fixed predetermined frequency.</s><s xml:id="_m8FesSJ">One study 40 used real-time medication monitoring in which patients were sent a text message reminder only if the participant failed to open the medication dispenser.</s><s xml:id="_v9sDMsP">Five studies <ref type="bibr">30,</ref><ref type="bibr">31,</ref><ref type="bibr">36,</ref><ref type="bibr">38,</ref><ref type="bibr">41</ref> incorporated personalization into their messages.</s><s xml:id="_WFgvEps">For example, the trial by Khonsari et al 31 used the following personalization: [Mr or Ms] [patient name], please take [medicine quantity] tablet of [medication name] at [time].</s><s xml:id="_vVzrMej">Eight studies used a 2-way communication strategy, which was mandatory in 4 studies <ref type="bibr">30,</ref><ref type="bibr">32,</ref><ref type="bibr">36,</ref><ref type="bibr">41</ref> and encouraged in 4 studies. <ref type="bibr" target="#b20">21,</ref><ref type="bibr">[33]</ref><ref type="bibr">[34]</ref></s><s xml:id="_ZrdBn8R">4]<ref type="bibr">[35]</ref> The message content was predominantly medication reminders <ref type="bibr">31,</ref><ref type="bibr">[33]</ref><ref type="bibr">[34]</ref><ref type="bibr">[35]</ref><ref type="bibr">[36]</ref><ref type="bibr">[37]</ref><ref type="bibr">[38]</ref><ref type="bibr">[39]</ref><ref type="bibr">[40]</ref><ref type="bibr">[41]</ref><ref type="bibr">[42]</ref><ref type="bibr">[43]</ref> but also included medical educational information <ref type="bibr" target="#b20">21,</ref><ref type="bibr">33,</ref><ref type="bibr">[35]</ref><ref type="bibr">[36]</ref><ref type="bibr">[37]</ref><ref type="bibr">43</ref> or nonmedical general topics <ref type="bibr">29,</ref><ref type="bibr">30,</ref><ref type="bibr">32</ref> (eg, jokes, Bible verses, humor, Figure 1. St</s><s xml:id="_RQ5j44G">dy Selection Process 1987 Records identified through database searching 1508 Records after duplicates removed 1508 Records screened 44 Full-text articles assessed for eligibility 16 RCTs included in qualitative synthesis 16 RCTs included in quantitative synthesis (meta-analysis) 1464 Records excluded 28 Articles excluded 8 4 7 8 1 Not appropriate population Not a chronic disease setting No numerical data on outcomes of interest Not eligible study design Text message not primary intervention RCTs indicates randomized clinical trials.</s></p><p xml:id="_CPpZrPP"><s xml:id="_GWwHThs">Copyright 2016 American Medical Association.</s><s xml:id="_kBFhrHN">All rights reserved.</s></p><p xml:id="_TnwNHqw"><s xml:id="_fJjH9Qm">etc).</s><s xml:id="_pDXQyvs">With respect to frequency; the most common pattern was a daily text message in 8 studies, <ref type="bibr" target="#b20">21,</ref><ref type="bibr">30,</ref><ref type="bibr">31,</ref><ref type="bibr">[36]</ref><ref type="bibr">[37]</ref><ref type="bibr">[38]</ref><ref type="bibr">[39]</ref><ref type="bibr">42</ref> followed by a weekly text message in 3 studies. <ref type="bibr">32,</ref><ref type="bibr">35,</ref></s><s xml:id="_wm6jmkt">5,<ref type="bibr">37</ref> Only 1 study 41 used a variable frequency pattern, with daily send for 2 weeks, followed by alternate days for 2 weeks, and then weekly for the remainder of the study duration.</s><s xml:id="_72NAY7N">Four studies <ref type="bibr">31,</ref><ref type="bibr">36,</ref><ref type="bibr">40,</ref><ref type="bibr">41</ref> matched message send times with the time of patients' medication doses.</s><s xml:id="_DY55SB8">The sending of messages was managed by automation or computer programs in 10 studies. <ref type="bibr">[29]</ref><ref type="bibr">[30]</ref><ref type="bibr">[31]</ref></s><s xml:id="_BxEMCxK">31]<ref type="bibr">[32]</ref><ref type="bibr">[33]</ref><ref type="bibr">36,</ref><ref type="bibr">38,</ref><ref type="bibr">40,</ref><ref type="bibr">41,</ref><ref type="bibr">43</ref> Meta-analysis of the Intervention Efficacy</s></p><p xml:id="_YdRTehU"><s xml:id="_MYsCq8f">In the pooled analysis of 2742 patients, text message interventions significantly improved medication adherence (OR, 2.11; 95% CI, 1.52-2.93;</s><s xml:id="_ryKNvEf">P &lt; .001)</s><s xml:id="_xtxYwA2">(Figure <ref type="figure" target="#fig_0">2</ref>).</s><s xml:id="_EJrjebB">The weighted mean effect size (Cohen d) was 0.41 (95% CI, 0.23-0.59).</s><s xml:id="_NH46DRY">Text message interventions were similarly effective when analyses were restricted to text message studies <ref type="bibr">31,</ref><ref type="bibr">32,</ref><ref type="bibr">34,</ref><ref type="bibr">35,</ref><ref type="bibr">37,</ref><ref type="bibr">[40]</ref><ref type="bibr">[41]</ref><ref type="bibr">[42]</ref> reporting outcomes by intent to treat (OR, 2.25; 95% CI, 1.51-3.37;</s><s xml:id="_JvHJPzN">P &lt; .001;</s><s xml:id="_nzEfKDW">Cohen d, 0.45) (eFigure 1 in the Supplement) or by per-protocol analysis (OR, 1.65; 95% CI, 1.07-2.53;</s><s xml:id="_7XkWV8w">P = .02;</s><s xml:id="_5ZxdGyx">Cohen d, 0.28) (eFigure 2 in the Supplement).</s><s xml:id="_YXQz7sk">We did not find significant effects of text messages on adherence in subgroup analysis based on text message characteristics and study variables (Table <ref type="table" target="#tab_6">3</ref>).</s><s xml:id="_dcEs3vk">There was moderate heterogeneity (I 2 = 62%) across clinical trials.</s><s xml:id="_P7f7kEE">Publication bias was detected by funnel plot asymmetry (eFigure 3 in the Supplement) and Egger regression coefficient (1-tailed P = .02).</s><s xml:id="_GFBKZ8p">Using trim-and-fill imputation for missing studies, the point estimate was reduced but remained positive, with an OR of 1.68 (95% CI, 1.18-2.39;</s><s xml:id="_VSZxvFU">P &lt; .05).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_KRS5ZD3">Risk of Bias and Sensitivity Analysis</head><p xml:id="_VEXwHNw"><s xml:id="_CJqfjs4">We performed a sensitivity analysis based on the quality of studies.</s><s xml:id="_UaypQ7s">Fourteen studies described a randomization se-quence generation technique that was at low risk of bias.</s><s xml:id="_75hy6nc">Ten studies used a low-risk method for randomization concealment.</s><s xml:id="_V2hxWgC">Masking of study participants was not possible be- cause of the nature of the intervention.</s><s xml:id="_VUCUNex">Masking of outcome assessment was not clearly described in most studies.</s><s xml:id="_WzYQhJ9">Almost half of the studies performed their primary analysis according to the principles of intent to treat.</s><s xml:id="_3QNGYvM">Overall, 10 studies were thought to be of high quality (eFigure 4 and eTable 2 in the Supplement).</s><s xml:id="_SBdsruM">Text messaging improved adherence even when we included only high-quality studies 29,32-37,40-42 (OR, 1.67; 95% CI, 1.21-2.29;</s><s xml:id="_w34dzfU">P = .002).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_2WHKzTV">Text Message Acceptability</head><p xml:id="_yWtZASt"><s xml:id="_gGrrpap">Participant feedback on text message acceptability was reported in 11 studies (Table <ref type="table" target="#tab_3">2</ref>).</s><s xml:id="_t7w8Gbm">Most reported moderate to high 0.1 1 10 0.5 2 5 0.2</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_YQzUB2d">Favors Control</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_jvNyf9p">Favors Text Message</head><p xml:id="_TqgAPdG"><s xml:id="_VzS9rgq">Odds Ratio (95% CI)</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_CxU79bj">Source</head><p xml:id="_hVBTzaS"><s xml:id="_ehkdwp7">Odds Ratio (95% CI)</s></p><p xml:id="_cwx4Uy4"><s xml:id="_epYdrB7">Statistics for Each Study P Value Márquez Contreras et al, 43 2004 da Costa et al, 29 2012 Hardy et al, 30 2011 a Khonsari et al, 31 2015 a Lester et al, 32 2010 Lv et al, 21 2012 Lua and Neni, 33 2013 Maduka and Tobin-West, 34 2013 Mbuagbaw et al, 35 2012 Park et al, 36 2014 Pop-Eleches et al, 37 2011 Quilici et al, 38 2013 Strandbygaard et al, 39 2010 Vervloet et al, 40 2012 Wald et al, 41 2014 Wang et al, 42 2014 1.508 2.571 21.131 12.273 1.612 2.074 0.985 2.644 1.026 0.610 1.330 2.705 6.018 2.959 3.267 3.857 (0.631-3.605) (0.371-17.831) (3.161-141.237)</s><s xml:id="_M86tWRZ">(3.405-44.236)</s><s xml:id="_gYmwBbG">(1.144-2.271)</s><s xml:id="_QDUCWbD">(0.686-6.251) (0.535-1.812) (1.135-6.160)</s><s xml:id="_92nNgG7">(0.519-2.026) (0.236-1.585) (0.882-2.005) (1.109-6.596)</s><s xml:id="_BV4Swh8">(1.368-26.466)</s><s xml:id="_9uhhDXX">(1.448-6.046)</s><s xml:id="_5vMYsfM">(1.686-6.331)</s><s xml:id="_hNSbMYH">(1.180-12.606)</s><s xml:id="_KpqR62t">.36</s><s xml:id="_usNxBUX">.34</s><s xml:id="_4xSMDNc">.002</s><s xml:id="_bE7a427">&lt;.001 .006</s><s xml:id="_RJzbjQJ">.20 .96</s><s xml:id="_b2BB2Zp">.02</s><s xml:id="_wdBceky">.94</s><s xml:id="_WmCPY3j">.31</s><s xml:id="_EDWPxre">.17</s><s xml:id="_j8QNSnY">.03</s><s xml:id="_wuzNt7p">.02</s><s xml:id="_8cC77rG">.003</s><s xml:id="_A4N3MmC">&lt;.001 .03</s><s xml:id="_FxZ8pWF">Overall 2.107 &lt;.001 (1.517-2.926)</s><s xml:id="_h8huh7s">a The text message intervention significantly improved adherence (odds ratio, 2.11; 95% CI, 1.52-2.93;</s><s xml:id="_FxU7k8Q">P &lt; .001).</s><s xml:id="_g6vWaad">The effect remained significant after excluding 2 studies with extreme outcomes (Hardy et al 30 and Kohnsari et al 31 ) (odds ratio, 1.78; 95% CI, 1.35-2.35;</s><s xml:id="_hWKCQPc">P &lt; .001).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_VkXRMkx">Discussion</head><p xml:id="_TA8pQNM"><s xml:id="_cTnePPh">We identified 16 RCTs that investigated the effect of text messaging on medication adherence in patients with chronic disease.</s><s xml:id="_YmZbZTp">We found that text message interventions increased medication adherence, with an approximate doubling of the odds of patients' achieving adherence to their medication regimens.</s><s xml:id="_6dEUDJr">This increase translates into adherence rates improving from 50% (assuming this percentage as the baseline rate in patients with chronic disease from the literature in developing countries <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b6">7</ref> ) to 67.8%, or an absolute increase of 17.8%.</s><s xml:id="_Mrs7ZD4">Given the simplicity of the intervention and potential scalability, this finding suggests that text message-based in-terventions could have substantial potential to improve medication adherence in patients with chronic disease.</s><s xml:id="_6sM3ect">Our findings are consistent with previous observations that text messaging can be a useful tool for behavioral change in disease prevention 44 and monitoring and management. <ref type="bibr">45,</ref><ref type="bibr">46</ref></s><s xml:id="_Ppsg7G6">Our analyses indicated the presence of publication bias.</s><s xml:id="_UrhTmTC">However, even after taking this bias into account, the effect estimate was still significantly positive.</s><s xml:id="_YzZBuxP">There was also substantial heterogeneity noted, which is likely because of several reasons, including clinical heterogeneity (true variation of effect arising from variation in the characteristics of the text message interventions and variation in the patient populations).</s><s xml:id="_YbMC53V">Nevertheless, there is also likely methodological heterogeneity, most likely arising because of variability in the ways outcomes were defined and measured in each study.</s><s xml:id="_pJhJhrS">Improving medication adherence is a challenge.</s><s xml:id="_wrENGGX">Various interventions targeting medication adherence have been reported, including patient education and counseling, allied health support (pharmacist-based or nurse-led interventions), use of reminders (beepers, pagers, smartphone apps, and automated telephone calls), packaged medications, and frequent clinic visits. <ref type="bibr" target="#b0">1</ref> Successful strategies usually involve multimodal combinations.</s><s xml:id="_eCffGK2">However, implementing such complex combination methods is resource intensive and may not Another area of interest is the effect of text message characteristics.</s><s xml:id="_jdTMcfP">The characteristics of interventions in this metaanalysis varied substantially.</s><s xml:id="_feMK7T2">While certain characteristics of text message-based programs such as increased message frequency and 2-way communication have been suggested to improve outcomes, we found no significant heterogeneity of effects across subgroups within this review.</s><s xml:id="_DACdWzF">However, the results of a comparative analysis between these subgroups should be interpreted with caution and regarded as inconclusive because of sparse data available for analysis.</s><s xml:id="_c5sZCzk">However, some aspects are noteworthy.</s><s xml:id="_eMTR3ZF">Interventions that delivered personalized messages showed a moderate effect size (Cohen d, 0.63; 95% CI, 0.29-0.96;</s><s xml:id="_CDU7prF">P &lt; .01),</s><s xml:id="_PVDfg5C">which suggests that sending a text message with one's preferred name may increase acceptance and participant engagement.</s><s xml:id="_yAcWwhU">There was no significant difference between daily text messages (Cohen d, 0.48; 95% CI, 0.17-0.79)</s><s xml:id="_fcJx8jQ">compared with less frequent messaging (Cohen d, 0.35; 95% CI, 0.13-0.57),</s><s xml:id="_gNsSQBw">which is contrary to concerns raised in other studies 37,48 that daily reminders may lead to habituation and response fatigue.</s><s xml:id="_QJHBMFj">However, one possible explanation is that response fatigue may be a feature of longer-duration interventions, while the median length of studies in this review was 3 months.</s></p><p xml:id="_bC3QsEx"><s xml:id="_3Ur4fZ8">Overall, the text message intervention had high acceptance rates.</s><s xml:id="_DVwuXGD">The patients in our meta-analysis were middleaged (age range, 31-64 years), and 50.3% (1380 of 2742) were female.</s><s xml:id="_f9y3JAc">Most studies did not report the educational or socioeconomic status of the participants.</s><s xml:id="_HAkbnEy">Hence, there were insufficient data to determine whether these individual characteristics may be associated with variation in response.</s></p><p xml:id="_u229hrK"><s xml:id="_fqZqgAw">While there has been mounting evidence largely in favor of texting interventions, many questions remain unanswered.</s><s xml:id="_9vV26Jv">There is a need for future high-quality studies to address more comprehensively what features of programs make them more effective.</s><s xml:id="_kcuHU9W">For example, is there greater benefit with more text message sophistication such as fixed-frequency or real-time medication monitoring, matched short message service with medication times, varied message content, personalization, and 2-way communication?</s><s xml:id="_fFJ6EHv">Also, do text message-based interventions work better in some groups of patients compared with others?</s><s xml:id="_nw4mtzP">For example, do they vary based on participant characteristics such as nonadherence, cultural background, type of disease, educational level, and socioeconomic class?</s><s xml:id="_MtXQkjh">This information will help inform how best to formulate text message-based interventions for different patient cohorts.</s></p><p xml:id="_JjUc2kp"><s xml:id="_bwKWwAE">One unique feature of text message interventions is the ability to offer confidential and unobtrusive support, which is an advantage of text messaging over other electronic reminders such as pagers or beepers.</s><s xml:id="_XnvxCuf">In the study by Hardy et al, 30 one-third of the control subjects objected to the use of beepers, which provoked curiosity from people around them and violated confidentiality.</s><s xml:id="_fExwq4X">This concern was not reported in association with the text message intervention arm in any study, perhaps because of widespread use and recognition of conventional text message alert tones, which are less likely to arouse curiosity among peers.</s><s xml:id="_VQEd9pD">There is still a potential for problems in the case of unattended mobile telephones without password lock or smartphones with a message preview function, but these concerns can be managed with appropriate participant training.</s></p><p xml:id="_tdwCvzV"><s xml:id="_g5pYVq5">There are several limitations of our meta-analysis.</s><s xml:id="_9RMpQhD">First, this study is subject to publication bias, although the effect of publication bias is likely small based on the fail-safe N test by Orwin. <ref type="bibr">49</ref></s><s xml:id="_865tMgg">This test provides an estimate of the number of missing studies.</s><s xml:id="_per3995">At a generally acceptable threshold of 0.1 for the effect size, this value was 34, which means that we would need to locate an additional 34 studies with a mean standard difference in means of 0 to bring the combined standard difference in means to below 0.1.</s><s xml:id="_gcPyEED">Second, the adherence levels that defined patients as adherent varied among the studies.</s><s xml:id="_CbxQssx">For example, these thresholds in HIV studies were 90% in the study by Pop-Eleches et al 37 vs 95% in the study by Lester et al; <ref type="bibr">32</ref> and in CVD studies they were 80% in the study by Wald et al 41 vs 95% in the study by Quilici et al <ref type="bibr">38</ref> .</s><s xml:id="_cNPshYc">If the threshold is lowered, it can overestimate the effect of text messaging on adherence and vice versa.</s><s xml:id="_fXAWGfr">Third, many studies used self-reporting to determine the outcomes, which carries the possibility of recall bias and social desirability bias.</s><s xml:id="_sV5Nf4R">Self-recall is commonly used to measure adherence owing to the convenience, the lack of a criterion standard, and the challenges of recording behaviors objectively.</s><s xml:id="_jrvknbY">However, it tends to overestimate adherence, and there is no consensus on optimal recall periods (3 days, 7 days, or 1 month). <ref type="bibr">50</ref></s><s xml:id="_UCgECKK">Social desirability bias may also be an important consideration in the studies included given their cultural diversity.</s><s xml:id="_ZW8nqd9">Fourth, the RCTs identified in our metaanalysis had short intervention duration and follow-up (median, 12 weeks), and none of the studies reported data on adherence behavior beyond the end of the trial or completion of the intervention.</s><s xml:id="_AcfaeEK">The short duration of the trials suggests uncertainty about the duration of the effect, the time-effect relationship, and the continuation or decay of the effect after the intervention is withdrawn.</s><s xml:id="_G2y3uwX">While our meta-analysis identified a positive effect of text messaging on medication adherence in the short term, it is uncertain if this influence will translate into longer-term effects on adherence behavior or on clinical outcomes.</s></p><p xml:id="_UFdY4KM"><s xml:id="_6wyHTNq">Text Messaging for Medication Adherence in Chronic Disease Original Investigation Research jamainternalmedicine.com (Reprinted) JAMA Internal Medicine March 2016 Volume 176, Number 3</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_UPa9JMP">Conclusions</head><p xml:id="_cBvuZBp"><s xml:id="_GKPdS93">We found that mobile telephone text messaging increased adherence to taking medications among middle-aged patients with chronic disease.</s><s xml:id="_pKJYuga">The ease of use, instantaneous relay of information, and boundless reach make it an attractive tool for public health.</s><s xml:id="_GxehpVe">While our analyses indicate some heterogeneity across clinical trials, this finding is likely because of variation in the characteristics of the interventions studied and in the definitions of outcomes among the studies.</s><s xml:id="_7vhxZve">These results should be interpreted with caution given that most trials were of short duration and that most used self-reported outcome measures.</s><s xml:id="_JN7ymAD">Hence, uncertainty remains about the effect size of text messages over longer periods and on objective measures of outcome.</s><s xml:id="_gRgPWWv">Future research on the benefit of different features of text message interventions, the longevity of the effect, and the influence on objective clinical measures of outcomes are needed to help better identify the role of text message interventions to improve medication adherence in chronic disease care.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 2 .</head><label>2</label><figDesc><div><p xml:id="_zQUSXFy"><s xml:id="_VuvU3Jc">Figure 2. Meta-analysis of the Effect of a Mobile Telephone Text Message Intervention on Medication Adherence</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_A9KpPwq"><s xml:id="_yCsXd66">Characteristics of the Randomized Clinical Trials Using Text Messaging to Promote Medication Adherence</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell>Sample</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>Size</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>(Inter-</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Chronic</cell><cell>vention</cell><cell>Experimental Arm vs</cell><cell>Participant Age,</cell><cell>Female</cell><cell></cell><cell></cell></row><row><cell>Source</cell><cell>Disease</cell><cell>Duration)</cell><cell>Control Arm</cell><cell>Mean (SD), y</cell><cell cols="2">Sex, % Setting/Country</cell><cell>Participant Characteristics</cell></row><row><cell>Márquez Contreras et al, 43</cell><cell>HT</cell><cell>n = 67 (6 mo)</cell><cell>TM vs standard care</cell><cell>56.2 (10.2) for IG and 59.4 (10.9) for CG</cell><cell>45</cell><cell>Outpatient/Spain</cell><cell>Uncontrolled HT on monotherapy regimen</cell></row><row><cell>2004</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>da Costa et al, 29</cell><cell>HIV</cell><cell>n = 21</cell><cell>TM vs standard care</cell><cell>36.1 (9.1) for IG and</cell><cell>100</cell><cell cols="2">University clinic/Brazil Stable patients with HIV</cell></row><row><cell>2012</cell><cell></cell><cell>(4 mo)</cell><cell></cell><cell>34.6 (6.9) for CG</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Hardy et al, 30</cell><cell>HIV</cell><cell>n = 23</cell><cell>TM vs beeper</cell><cell>42 (8) for IG and</cell><cell>47</cell><cell>HIV clinic/United</cell><cell>On ART regimen &gt;3 mo with</cell></row><row><cell>2011</cell><cell></cell><cell>(6 wk)</cell><cell></cell><cell>44 (4) for CG</cell><cell></cell><cell>States</cell><cell>self-reported adherence</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>&lt;85%</cell></row><row><cell>Khonsari et al, 31</cell><cell>CAD</cell><cell>n = 62</cell><cell>TM vs standard care</cell><cell>Median (range),</cell><cell cols="2">14.5 Hospital</cell><cell>Patients admitted to the</cell></row><row><cell>2015</cell><cell></cell><cell>(8 wk)</cell><cell></cell><cell>57.9 (12-64)</cell><cell></cell><cell>inpatient/Malaysia</cell><cell>hospital for management of</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>ACS</cell></row><row><cell>Lester et al, 32</cell><cell>HIV</cell><cell>n = 538</cell><cell>TM vs standard care</cell><cell>36.7 (8.5) for IG and</cell><cell>65</cell><cell>HIV clinic/Kenya</cell><cell>Initiated ART for the first</cell></row><row><cell>2010</cell><cell></cell><cell>(12 mo)</cell><cell></cell><cell>36.6 (7.9) for CG</cell><cell></cell><cell></cell><cell>time</cell></row><row><cell>Lua and Neni, 33</cell><cell cols="2">Epilepsy n = 136</cell><cell>TM vs standard care</cell><cell>31 (12)</cell><cell>49</cell><cell>Hospital outpatient</cell><cell>On regular treatment</cell></row><row><cell>2013</cell><cell></cell><cell>(3 mo)</cell><cell></cell><cell></cell><cell></cell><cell>clinic/Malaysia</cell><cell>regimen for epilepsy</cell></row><row><cell>Lv et al, 21 2012</cell><cell>Asthma</cell><cell>n = 71</cell><cell>TM vs traditional care vs</cell><cell>36.2 (11.1) for IG and</cell><cell>42</cell><cell>Hospital respiratory</cell><cell>Asthma diagnosed &gt;3 mo</cell></row><row><cell></cell><cell></cell><cell>(12 wk)</cell><cell>standard care</cell><cell>38.8 (12.0) for CG</cell><cell></cell><cell>department/China</cell><cell>and positive bronchodilator</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>provocation test result</cell></row><row><cell>Maduka and Tobin-West, 34</cell><cell>HIV</cell><cell>n = 104 (4 mo)</cell><cell>TM vs standard care</cell><cell>36.6 (11.7) for IG and 35.3 (9.0) for CG</cell><cell cols="2">56.7 Hospital outpatient clinic/Nigeria</cell><cell>HIV positive on HAART regimen for ≥3 mo</cell></row><row><cell>2013</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Mbuagbaw et al, 35 2012</cell><cell>HIV</cell><cell>(6 mo) n = 200</cell><cell>TM vs standard care</cell><cell>39.0 (10.0) for CG 41.3 (10.3) for IG and</cell><cell cols="2">clinic/Cameroon 73.5 Hospital</cell><cell>On ART regimen &gt;1 mo</cell></row><row><cell>Park et al, 36</cell><cell>CAD</cell><cell>n = 90</cell><cell cols="2">TM vs TM vs standard care Median (range),</cell><cell>24</cell><cell>Hospital</cell><cell>Admitted for STEMI,</cell></row><row><cell>2014</cell><cell></cell><cell>(30 d)</cell><cell></cell><cell>59.2 (35-83)</cell><cell></cell><cell>inpatient/United States</cell><cell>NSTEMI, or PCI</cell></row><row><cell>Pop-Eleches et al, 37 2011</cell><cell>HIV</cell><cell>n = 428 (48 wk)</cell><cell>TM vs standard care</cell><cell>36.3</cell><cell>66</cell><cell>HIV clinic/Kenya</cell><cell>Initiated antiretroviral therapy &lt;3 mo</cell></row><row><cell>Quilici et al, 38</cell><cell>CAD</cell><cell>n = 521</cell><cell>TM vs standard care</cell><cell>64 (10) for IG and</cell><cell>24</cell><cell>Hospital</cell><cell>Coronary stenting for ACS</cell></row><row><cell>2013</cell><cell></cell><cell>(1 mo)</cell><cell></cell><cell>64 (14) for CG</cell><cell></cell><cell>inpatient/France</cell><cell>(aspirin resistance excluded</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>by platelet function testing)</cell></row><row><cell>Strandbygaard et al, 39 2010</cell><cell>Asthma</cell><cell>n = 26 (12 wk)</cell><cell>TM vs standard care</cell><cell>Range, 18-45</cell><cell>46</cell><cell>Newspaper advertisement/Denmark</cell><cell>Asthma history and positive methacholine test result</cell></row><row><cell>Vervloet et al, 40</cell><cell>Diabetes</cell><cell>n = 104</cell><cell>RTMM-TM vs standard</cell><cell>54.9 (6.6) for IG and</cell><cell>45</cell><cell>Pharmacies/the</cell><cell>Oral diabetic for &gt;1 y and/or</cell></row><row><cell>2012</cell><cell>mellitus</cell><cell>(6 mo)</cell><cell>care</cell><cell>54.6 (6.9) for CG</cell><cell></cell><cell>Netherlands</cell><cell>insulin &gt;6 mo and known</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>adherence &lt;80% based on</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>pharmacy dispensing data</cell></row><row><cell>Wald et al, 41</cell><cell>CVD</cell><cell>n = 303</cell><cell>TM vs standard care</cell><cell>Median (range),</cell><cell>46</cell><cell>Primary care</cell><cell>Patients receiving blood</cell></row><row><cell>2014</cell><cell></cell><cell>(6 mo)</cell><cell></cell><cell>60 (54-68) for</cell><cell></cell><cell>clinic/London, England</cell><cell>pressure and lipid-lowering</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>IG and 41 (49-69) for</cell><cell></cell><cell></cell><cell>therapy for prevention of</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>CG</cell><cell></cell><cell></cell><cell>CVD</cell></row><row><cell>Wang et al, 42</cell><cell>Allergic</cell><cell>n = 50</cell><cell>TM vs standard care</cell><cell>35.7 (8.8) for IG and</cell><cell>60</cell><cell>Outpatient/China</cell><cell>Allergic rhinitis history and</cell></row><row><cell>2014</cell><cell>rhinitis</cell><cell>(30 d)</cell><cell></cell><cell>31.0 (10.8) for CG</cell><cell></cell><cell></cell><cell>positive skin prick test result</cell></row></table><note xml:id="_nDsA8VQ"><p><s xml:id="_hVGeEVT">Abbreviations: ACS, acute coronary syndrome; ART, antiretroviral therapy; CAD, coronary artery disease; CG, control group; CVD, cardiovascular disease; HAART, highly active antiretroviral therapy; HIV, human immunodeficiency virus; HT, hypertension; IG, intervention group; NSTEMI, non-ST-segment elevation myocardial infarction; PCI, percutaneous coronary intervention; RTMM, real-time medication monitoring; STEMI, ST-segment elevation myocardial infarction; TM, text message.</s><s xml:id="_8xDc6j2">Text Messaging for Medication Adherence in Chronic Disease Original Investigation Research jamainternalmedicine.com (Reprinted) JAMA Internal Medicine March 2016 Volume 176, Number 3</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 2 .</head><label>2</label><figDesc><div><p xml:id="_4H9HyvA"><s xml:id="_zepUj8c">Features of the Text Messaging Design Used in the Randomized Clinical Trials</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell>TM Content and Other</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>TM Frequency (No. of</cell><cell>Characteristics</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Days per Week/No. of</cell><cell>(Personalization/Frequency</cell><cell>Mobile Telephone</cell><cell></cell><cell></cell></row><row><cell></cell><cell>TMs per Day/Message</cell><cell>Tailoring/2-Way</cell><cell>Ownership/Incentives/</cell><cell>Outcome Measure/Outcome</cell><cell></cell></row><row><cell>Source</cell><cell>Send Method)</cell><cell>Communication)</cell><cell>Additional Support</cell><cell>Ascertainment Method</cell><cell>Patient Feedback</cell></row><row><cell>Márquez</cell><cell>Twice per</cell><cell>1-Way</cell><cell>Personal mobile</cell><cell>Mean percentage</cell><cell>Not reported</cell></row><row><cell>Contreras et al, 43 2004</cell><cell>week/random weekdays/between 11</cell><cell></cell><cell>telephone</cell><cell>compliance/adherent patients (&gt;80% of</cell><cell></cell></row><row><cell></cell><cell>AM and 14</cell><cell></cell><cell></cell><cell>medications taken)/pill</cell><cell></cell></row><row><cell></cell><cell>PM/automated</cell><cell></cell><cell></cell><cell>count</cell><cell></cell></row><row><cell></cell><cell>commercial platform</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>da Costa et al, 29</cell><cell>Weekends and</cell><cell>1-Way TM/general content</cell><cell>Personal mobile</cell><cell>Proportion of patients</cell><cell>80% Provided</cell></row><row><cell>2012</cell><cell>alternate days during</cell><cell>(covert)/"The UNIFESP</cell><cell>telephone</cell><cell>adherent (&gt;95% of</cell><cell>feedback/100% of</cell></row><row><cell></cell><cell>weekdays/automated</cell><cell>informs: take good care of</cell><cell></cell><cell>medications</cell><cell>respondents reported that</cell></row><row><cell></cell><cell>send engine</cell><cell>your health"</cell><cell></cell><cell>taken)/self-recall, pill count,</cell><cell>messages helped them take</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>MEMS</cell><cell>medications/90% would like</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>to continue receiving TMs</cell></row><row><cell>Hardy et al, 30</cell><cell>Daily/automated send</cell><cell>2-Way personalized TM,</cell><cell>Study provided a mobile</cell><cell>Proportion of doses</cell><cell>Most intervention</cell></row><row><cell>2011</cell><cell>engine (ARemind;</cell><cell>patient had to respond with</cell><cell>telephone with an</cell><cell>taken/self-recall (7 d)/pill</cell><cell>participants reported they</cell></row><row><cell></cell><cell>Dimagi Inc)</cell><cell>a TM when taking ART. If no</cell><cell>unlimited calling and</cell><cell>count (30 d)/MEMS</cell><cell>would continue using a</cell></row><row><cell></cell><cell></cell><cell>response, the telephone</cell><cell>texting plan</cell><cell></cell><cell>program to help remind</cell></row><row><cell></cell><cell></cell><cell>would beep every 15 min</cell><cell></cell><cell></cell><cell>them to take</cell></row><row><cell></cell><cell></cell><cell>until the patient</cell><cell></cell><cell></cell><cell>medications/one-third of</cell></row><row><cell></cell><cell></cell><cell>acknowledges the</cell><cell></cell><cell></cell><cell>control participants</cell></row><row><cell></cell><cell></cell><cell>TM/general content</cell><cell></cell><cell></cell><cell>objected to the beeper,</cell></row><row><cell></cell><cell></cell><cell>(weather, jokes, Bible verses,</cell><cell></cell><cell></cell><cell>which provoked curiosity</cell></row><row><cell></cell><cell></cell><cell>sports, news, humor)</cell><cell></cell><cell></cell><cell>from people around them</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>and violated confidentiality</cell></row><row><cell>Khonsari et al, 31</cell><cell>Daily before every</cell><cell>Personalized 1-way</cell><cell>Personal mobile</cell><cell>Proportion of patients</cell><cell>93.5% Reported that TMs</cell></row><row><cell>2015</cell><cell>intake of</cell><cell>TM/content of reminder is</cell><cell>telephone/telephone</cell><cell>adherent/self-report (MMAS</cell><cell>were useful, and &gt;80%</cell></row><row><cell></cell><cell>medication/automated</cell><cell>[Mr or Ms] [patient name],</cell><cell>contact 1-2 times per</cell><cell>8 item)</cell><cell>requested that TM</cell></row><row><cell></cell><cell>send</cell><cell>please take [medicine</cell><cell>week to TM group to</cell><cell></cell><cell>reminders should be</cell></row><row><cell></cell><cell></cell><cell>quantity] tablet of</cell><cell>confirm delivery of TM</cell><cell></cell><cell>continued</cell></row><row><cell></cell><cell></cell><cell>[medication name] at [time]</cell><cell>and remind patients</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>about appointments</cell><cell></cell><cell></cell></row><row><cell>Lester et al, 32</cell><cell>Weekly (Monday</cell><cell>Slogan is "Mambo?"</cell><cell>Personal mobile</cell><cell>Proportion of patients</cell><cell>Most patients recommended</cell></row><row><cell>2010</cell><cell>morning)/bulk TM</cell><cell>(meaning "How are</cell><cell>telephone/clinic called</cell><cell>adherent (&gt;95% of</cell><cell>continuing the TM program</cell></row><row><cell></cell><cell>service</cell><cell>you")/response expected</cell><cell>patients who said they</cell><cell>medications</cell><cell>(data not shown in the</cell></row><row><cell></cell><cell></cell><cell>within 48 h is "Sawa" (doing</cell><cell>had a problem or failed</cell><cell>taken)/self-report</cell><cell>primary results article)</cell></row><row><cell></cell><cell></cell><cell>well) or "Shida" (problem)</cell><cell>to respond within 48 h</cell><cell></cell><cell></cell></row><row><cell>Lua and Neni, 33</cell><cell>TM every fourth day</cell><cell>Epilepsy knowledge,</cell><cell>Personal mobile</cell><cell>Mean adherence</cell><cell>Not reported</cell></row><row><cell>2013</cell><cell>delivered at 10</cell><cell>medication adherence, clinic</cell><cell>telephone/support for</cell><cell>rate/self-recall (Malay</cell><cell></cell></row><row><cell></cell><cell>AM/computerized</cell><cell>appointment</cell><cell>simple comments is</cell><cell>MMAS 4 item)</cell><cell></cell></row><row><cell></cell><cell>automated send (MEES</cell><cell>reminder/2-way TM</cell><cell>provided by research</cell><cell></cell><cell></cell></row><row><cell></cell><cell>modular service)</cell><cell>exchange is possible</cell><cell>assistants</cell><cell></cell><cell></cell></row><row><cell cols="2">Lv et al, 21 2012 Twice-daily TMs at 10</cell><cell>Content is asthma education,</cell><cell>Personal mobile</cell><cell>Mean adherence</cell><cell>6% Considered TMs</cell></row><row><cell></cell><cell>AM and 8 PM</cell><cell>medications, triggers, and</cell><cell>telephone/clinic</cell><cell>rate/self-report</cell><cell>inconvenient</cell></row><row><cell></cell><cell></cell><cell>acute attacks/2-way TM</cell><cell>investigators responded</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>communication is possible</cell><cell>to patient queries</cell><cell></cell><cell></cell></row><row><cell>Maduka and Tobin-West, 34</cell><cell>and Thursday Twice a week (Monday</cell><cell>information and reminder to Adherence-related</cell><cell>telephone/researchers Personal mobile</cell><cell>adherent (&gt;95% of Proportion of patients</cell><cell>Not reported</cell></row><row><cell>2013</cell><cell>morning)/bulk TM</cell><cell>take HAART/participants are</cell><cell>offered counseling via</cell><cell>medications</cell><cell></cell></row><row><cell></cell><cell>service</cell><cell>encouraged to communicate</cell><cell>telephone on an</cell><cell>taken)/self-report (No. of</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>as-needed basis</cell><cell>pills missed in last 7 d)</cell><cell></cell></row><row><cell>Mbuagbaw et al, 35 2012</cell><cell>Weekly (Wednesday 9 AM)</cell><cell>Motivational TM with reminder component/</cell><cell>Personal mobile telephone</cell><cell>Proportion of patients adherent (&gt;95% of</cell><cell>Moderate (65%) level of satisfaction reported</cell></row><row><cell></cell><cell></cell><cell>callback number is provided,</cell><cell></cell><cell>medications taken)/visual</cell><cell></cell></row><row><cell></cell><cell></cell><cell>but a reply TM is not</cell><cell></cell><cell>analog scale/pharmacy refill</cell><cell></cell></row><row><cell></cell><cell></cell><cell>mandatory</cell><cell></cell><cell>data</cell><cell></cell></row><row><cell>Park et al, 36</cell><cell>Reminder sent daily</cell><cell>Reminders and</cell><cell>Personal mobile</cell><cell>Proportion of doses</cell><cell>Most reported moderate to</cell></row><row><cell>2014</cell><cell>matched to medication</cell><cell>education/2-way,</cell><cell>telephone</cell><cell>taken/MEMS/MMAS 8 item</cell><cell>strong satisfaction with the</cell></row><row><cell></cell><cell>dose time/educational</cell><cell>personalized, with a reply</cell><cell></cell><cell></cell><cell>TM program and ease of use</cell></row><row><cell></cell><cell>material sent Monday,</cell><cell>required from the</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Wednesday, and Friday</cell><cell>participant/"John, take</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>at 2 PM/customizable</cell><cell>(medication name)</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>commercial platform</cell><cell>(medication dose) at 9 AM,</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>(CareSpeak; CareSpeak</cell><cell>respond with 1"</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Communications)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Pop-Eleches et al, 37 2011</cell><cell>(daily TM arm and Multiple-arm study</cell><cell>address barriers to 1-Way TM designed to</cell><cell>telephone to the Study provided a mobile</cell><cell>adherent (≥90% of Proportion of patients</cell><cell>Not reported</cell></row><row><cell></cell><cell>weekly TM</cell><cell>adherence/short message</cell><cell>participants and</cell><cell>medications taken)/MEMS</cell><cell></cell></row><row><cell></cell><cell>arm)/message sent at</cell><cell>(simple reminder)/long</cell><cell>financial support for</cell><cell></cell><cell></cell></row><row><cell></cell><cell>12 PM</cell><cell>message (additional</cell><cell>telephone credits and</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>support)</cell><cell>follow-up visit</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(continued)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>Table 2 .</head><label>2</label><figDesc><div><p><s xml:id="_fVe5MVF">Features of the Text Messaging Design Used in the Randomized Clinical Trials (continued)AM in the study by Wang et al 42 and 10 AM in the study by Strandbygaard et al 39 ) were not suitable because they tend to disrupt routines.</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell>TM Content and Other</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>TM Frequency (No. of</cell><cell>Characteristics</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Days per Week/No. of</cell><cell>(Personalization/Frequency</cell><cell>Mobile Telephone</cell><cell></cell><cell></cell></row><row><cell></cell><cell>TMs per Day/Message</cell><cell>Tailoring/2-Way</cell><cell>Ownership/Incentives/</cell><cell>Outcome Measure/Outcome</cell><cell></cell></row><row><cell>Source</cell><cell>Send Method)</cell><cell>Communication)</cell><cell>Additional Support</cell><cell>Ascertainment Method</cell><cell>Patient Feedback</cell></row><row><cell>Quilici et al, 38</cell><cell>Daily</cell><cell>Personalized TM reminder</cell><cell>Personal mobile</cell><cell>Proportion of patients</cell><cell>High satisfaction (92%</cell></row><row><cell>2013</cell><cell>TM/computer-</cell><cell>about aspirin intake</cell><cell>telephone</cell><cell>adherent (≥95% of</cell><cell>reported that TM support</cell></row><row><cell></cell><cell>generated reminders</cell><cell></cell><cell></cell><cell>prescribed doses</cell><cell>was valuable)</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>taken)/self-report/platelet</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>function testing</cell><cell></cell></row><row><cell>Strandbygaard et al, 39 2010</cell><cell>Daily TM at 10 AM</cell><cell>Medication reminder ("Remember to take your</cell><cell>Personal mobile telephone</cell><cell>Proportion of doses taken</cell><cell>Overall perception of daily TM was positive/most</cell></row><row><cell></cell><cell></cell><cell>asthma medication morning</cell><cell></cell><cell></cell><cell>reported the 10 AM time as</cell></row><row><cell></cell><cell></cell><cell>and evening. From the</cell><cell></cell><cell></cell><cell>unsuitable</cell></row><row><cell></cell><cell></cell><cell>respiratory unit")</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Vervloet et al, 40</cell><cell>Real-time TM</cell><cell>Reminder ("Have you taken</cell><cell>Personal mobile</cell><cell>Proportion of doses taken</cell><cell>75% Reported that TM</cell></row><row><cell>2012</cell><cell>delivered only if</cell><cell>your medications yet? Please</cell><cell>telephone</cell><cell>within 4½ h of reminder</cell><cell>reminders were supportive</cell></row><row><cell></cell><cell>participant fails to</cell><cell>take your medications as</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>open dispenser</cell><cell>prescribed")</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Wald et al, 41</cell><cell>Daily for 2 wk, then</cell><cell>Personalized 2-way TM</cell><cell>Personal mobile</cell><cell>Proportion of patients</cell><cell>Not reported</cell></row><row><cell>2014</cell><cell>alternate days for 2</cell><cell>("Hello [name], have you</cell><cell>telephone/telephone</cell><cell>adherent (&gt;80% of</cell><cell></cell></row><row><cell></cell><cell>wk, then weekly for 6</cell><cell>taken your heart medication</cell><cell>call to participants</cell><cell>prescribed doses</cell><cell></cell></row><row><cell></cell><cell>mo/matched to</cell><cell>today?…")/participants are</cell><cell>responding "no"</cell><cell>taken)/self-report (doses</cell><cell></cell></row><row><cell></cell><cell>medication dose</cell><cell>required to text back "yes"</cell><cell></cell><cell>missed over previous 28 d)</cell><cell></cell></row><row><cell></cell><cell>time/automated send</cell><cell>or "no"</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>using a software</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>application</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Wang et al, 42</cell><cell>Daily TMs (7 AM on</cell><cell>Medication reminder ("Good</cell><cell>Personal mobile</cell><cell>Proportion of patients</cell><cell>95% Of patients indicated</cell></row><row><cell>2014</cell><cell>weekdays and 9 AM on</cell><cell>morning. Budesonide once a</cell><cell>telephone</cell><cell>adherent (≥95% of</cell><cell>they would like to</cell></row><row><cell></cell><cell>weekends)/daily TMs</cell><cell>day is effective. Please do</cell><cell></cell><cell>prescribed doses</cell><cell>participate in the ongoing</cell></row><row><cell></cell><cell>sent by technician</cell><cell>not forget to take your</cell><cell></cell><cell>taken)/self-report (doses</cell><cell>TM program until the end of</cell></row><row><cell></cell><cell></cell><cell>medications")</cell><cell></cell><cell>missed over previous 30 d)</cell><cell>the study/TM timing not</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>suitable (7 AM disrupted</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>daily routines)</cell></row></table><note xml:id="_cMNqzh5"><p><s xml:id="_m87ajfq">Abbreviations: ART, antiretroviral therapy; HAART, highly active antiretroviral therapy; HIV, human immunodeficiency virus; MEES, mobile epilepsy education system; MEMS, medication event monitoring system; MMAS, Modified Morisky Adherence Scale; TM, text message; UNIFESP, Universidade Federal de São Paulo (Federal University of São Paulo, Brazil).</s><s xml:id="_29q6QCw">Text Messaging for Medication Adherence in Chronic Disease Original Investigation Research jamainternalmedicine.com (Reprinted) JAMA Internal Medicine March 2016 Volume 176, Number 3 Copyright 2016 American Medical Association.</s><s xml:id="_2APuwwz">All rights reserved.</s><s xml:id="_pc4yepk">Downloaded from jamanetwork.com</s><s xml:id="_VyQhkJ8">by University of Iowa user on 07/11/2025 Copyright 2016 American Medical Association.</s><s xml:id="_pMBnNhn">All rights reserved.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6"><head>Table 3 .</head><label>3</label><figDesc><div><p xml:id="_RkadW4y"><s xml:id="_hhGDkrR">Effect of Text Messaging on Medication Adherence in Subgroups Stratified by TM and Study Characteristics</s></p></div></figDesc><table><row><cell></cell><cell>No. of Studies or</cell><cell></cell><cell>P Value for</cell><cell></cell></row><row><cell>Variable</cell><cell>Substudies</cell><cell>Odds Ratio (95% CI)</cell><cell>Heterogeneity</cell><cell></cell></row><row><cell>Daily TM frequency a</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Yes No</cell><cell>7 10</cell><cell>2.40 (1.37-4.16) 1.88 (1.26-2.81)</cell><cell>.50</cell><cell></cell></row><row><cell>TM matched to medication dose time</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Yes No</cell><cell>4 12</cell><cell>2.68 (1.42-5.05) 1.93 (1.33-2.80)</cell><cell>.77</cell><cell></cell></row><row><cell>Personalization</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Yes No</cell><cell>5 11</cell><cell>3.11 (1.68-5.73) 1.81 (1.25-2.61)</cell><cell>.14</cell><cell></cell></row><row><cell>TM content</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Medical General nonmedical</cell><cell>12 4</cell><cell>2.12 (1.41-3.17) 2.29 (1.06-4.96)</cell><cell>.85</cell><cell></cell></row><row><cell>2-Way communication</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Yes No</cell><cell>8 8</cell><cell>1.71 (1.08-2.71) 2.77 (1.67-4.58)</cell><cell>.17</cell><cell></cell></row><row><cell>Sample size</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>≤104 &gt;104</cell><cell>10 6</cell><cell>2.80 (1.78-4.40) 1.59 (1.03-2.44)</cell><cell>.07</cell><cell></cell></row><row><cell>Intervention duration, wk ≤12 &gt;12</cell><cell>8 8</cell><cell>2.55 (1.50-4.33) 1.87 (1.20-2.92)</cell><cell>.38</cell><cell>Abbreviations: MEMS, medication event monitoring system; TM, text message. a We defined daily text message</cell></row><row><cell>Type of chronic disease</cell><cell></cell><cell></cell><cell></cell><cell>frequency as at least 1 message per</cell></row><row><cell>Communicable Noncommunicable</cell><cell>6 10</cell><cell>1.84 (1.08-3.14) 2.32 (1.51-3.57)</cell><cell>.51</cell><cell>day. The study by Pop-Eleches et al 37 was split into a daily message arm and a weekly message arm for</cell></row><row><cell>Outcome ascertainment method b</cell><cell></cell><cell></cell><cell></cell><cell>the subgroup analysis.</cell></row><row><cell>Self-report MEMS</cell><cell>12 3</cell><cell>2.17 (1.44-3.26) 2.50 (0.97-6.46)</cell><cell>.34</cell><cell>b The study by Márquez Contreras et al 43 reported outcomes based on pill count only.</cell></row></table><note xml:id="_8NbDNSs"><p><s xml:id="_p9HM3Dw">Copyright 2016 American Medical Association.</s><s xml:id="_THG9Gbt">All rights reserved.</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_uJAg9dZ"><s xml:id="_zqSHFjD">Copyright 2016 American Medical Association.</s><s xml:id="_KYdwQ8f">All rights reserved.</s><s xml:id="_uJMT5ZR">Downloaded from jamanetwork.com</s><s xml:id="_KwAQbtx">by University of Iowa user on 07/11/2025</s></p></note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_MTWVKqN">ARTICLE INFORMATION</head><p xml:id="_JwewbmE"><s xml:id="_CNNWgDD">Accepted for Publication: November 16, 2015.</s></p><p xml:id="_2rcK7Kw"><s xml:id="_QF6RmuQ">Published Online: February 1, 2016.</s><s xml:id="_uZzyErM">doi:10.1001/jamainternmed.2015.7667.</s></p><p xml:id="_E4nVCam"><s xml:id="_uZhTNkY">Author Contributions: Dr Thakkar had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.</s><s xml:id="_GhYj89h">Study concept and design: Thakkar, Redfern, Chow.</s><s xml:id="_VX95r9D">Acquisition, analysis, or interpretation of data: All authors.</s><s xml:id="_DnEgDbt">Drafting of the manuscript: Thakkar, Kurup, Thiagalingam, Redfern, Chow.</s><s xml:id="_RKUBu7D">Critical revision of the manuscript for important intellectual content: Thakkar, Laba, Santo, Thiagalingam, Rogers, Woodward, Redfern, Chow.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_yb8n8Fk">Adherence to medication</title>
		<author>
			<persName><forename type="first">L</forename><surname>Osterberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Blaschke</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmra050100</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_g57X2vk">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">353</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="487" to="497" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-497.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_2C7MjaR">Medication adherence: its importance in cardiovascular outcomes</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Bryson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Rumsfeld</surname></persName>
		</author>
		<idno type="DOI">10.1161/circulationaha.108.768986</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qQcSmJb">Circulation</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="issue">23</biblScope>
			<biblScope unit="page" from="3028" to="3035" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119(23):3028-3035.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<idno type="DOI">10.26719/2015.21.6.379</idno>
		<title level="m" xml:id="_smgCHn6">Adherence to Long-term Therapies: Evidence for Action</title>
		<meeting><address><addrLine>Geneva, Switzerland</addrLine></address></meeting>
		<imprint>
			<publisher>World Health Organization</publisher>
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">World Health Organization. Adherence to Long-term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization; 2003.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_RFrhc7K">A systematic review of adherence to cardiovascular medications in resource-limited settings</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Bowry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Shrank</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Choudhry</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11606-011-1825-3</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jpJ8GkR">J Gen Intern Med</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1479" to="1491" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bowry AD, Shrank WH, Lee JL, Stedman M, Choudhry NK. A systematic review of adherence to cardiovascular medications in resource-limited settings. J Gen Intern Med. 2011;26(12):1479-1491.</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_AnBKgxt">Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Magid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Shetterly</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ahj.2007.12.011</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5Smq2rG">Am Heart J</title>
		<imprint>
			<biblScope unit="volume">155</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="772" to="779" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ho PM, Magid DJ, Shetterly SM, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008;155(4):772-779.</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_nhqFRS6">The &quot;cost&quot; of medication nonadherence: consequences we cannot afford to accept</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Chisholm-Burns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Spivey</surname></persName>
		</author>
		<idno type="DOI">10.1331/japha.2012.11088</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PD8BX76">J Am Pharm Assoc</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="823" to="826" />
			<date type="published" when="2003">2003. 2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chisholm-Burns MA, Spivey CA. The &quot;cost&quot; of medication nonadherence: consequences we cannot afford to accept. J Am Pharm Assoc (2003). 2012;52(6):823-826.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_tUKVuQ5">Interventions for helping patients to follow prescriptions for medications</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Haynes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mcdonald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">X</forename><surname>Garg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Montague</surname></persName>
		</author>
		<idno type="DOI">10.1002/14651858.cd000011</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_EjyPY4U">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">11</biblScope>
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev. 2002;(2):CD000011.</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_zVAbhBc">Interventions for enhancing medication adherence</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Haynes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ackloo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sahota</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">P</forename><surname>Mcdonald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Yao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5tms3ne">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">11</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;(2): CD000011.</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_CJaCcB2">Interventions for enhancing medication adherence</title>
		<author>
			<persName><forename type="first">R</forename><surname>Nieuwlaat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Wilczynski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Navarro</surname></persName>
		</author>
		<idno type="DOI">10.1002/14651858.cd000011.pub4</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_zJb8HdT">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">11</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;11:CD000011.</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_DBb5ZuZ">mHealth: new horizons for health through mobile technologies</title>
		<idno type="DOI">10.4258/hir.2012.18.3.231</idno>
		<ptr target="http://www.who.int/goe/publications/goe_mhealth_web.pdf" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_QpWnY7r">Global Observatory for eHealth Series</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<date type="published" when="2011-09-13">2011. September 13, 2015</date>
			<publisher>World Health Organization</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">World Health Organization. mHealth: new horizons for health through mobile technologies. Global Observatory for eHealth Series Vol 3. http: //www.who.int/goe/publications/goe_mhealth_web .pdf. Published 2011. Accessed September 13, 2015.</note>
</biblStruct>

<biblStruct xml:id="b10">
	<monogr>
		<idno type="DOI">10.1093/anb/9780198606697.013.00487</idno>
		<ptr target="http://www.fda.gov/downloads/MedicalDevices/.../UCM263366.pdf" />
		<title level="m" xml:id="_4NYfQQY">Mobile medical applications: guidance for industry and Food and Drug Administration staff</title>
		<imprint>
			<publisher>US Food and Drug Administration</publisher>
			<date type="published" when="2015-02-09">February 9, 2015. December 9, 2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">US Food and Drug Administration. Mobile medical applications: guidance for industry and Food and Drug Administration staff. http://www.fda .gov/downloads/MedicalDevices/.../UCM263366 .pdf. Issued February 9, 2015. Accessed December 9, 2015.</note>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<idno type="DOI">10.1093/law:epil/9780199231690/e514</idno>
		<ptr target="http://www.itu.int/en/ITU-D/Statistics/Documents/publications/mis2014/MIS2014_without_Annex_4.pdf" />
		<title level="m" xml:id="_H8Ycqc7">Measuring the Information Society Report</title>
		<imprint>
			<publisher>International Telecommunication Union</publisher>
			<date type="published" when="2014-09-13">2014. September 13, 2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">International Telecommunication Union. Measuring the Information Society Report. http: //www.itu.int/en/ITU-D/Statistics/Documents /publications/mis2014/MIS2014_without_Annex_4 .pdf. Published 2014. Accessed September 13, 2015.</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_msjP4A5">The role of mobile phones in increasing accessibility and efficiency in health care</title>
		<idno type="DOI">10.1093/ww/9780199540884.013.u39504</idno>
		<ptr target="http://www.vodafone.com/content/dam/vodafone/about/public_policy/policy_papers/public_policy_series_4.pdf" />
	</analytic>
	<monogr>
		<title level="s" xml:id="_dgzqSfj">The Vodafone Policy Paper Series</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<date type="published" when="2006-03">March 2006. September 13, 2015</date>
		</imprint>
		<respStmt>
			<orgName>Vodafone Group Plc</orgName>
		</respStmt>
	</monogr>
	<note type="raw_reference">Vodafone Group Plc. The role of mobile phones in increasing accessibility and efficiency in health care. The Vodafone Policy Paper Series 4. http: //www.vodafone.com/content/dam/vodafone /about/public_policy/policy_papers/public_policy _series_4.pdf. Published March 2006. Accessed September 13, 2015.</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_vr3xmK2">Orientations in adolescent use of information and communication technology: a digital divide by sociodemographic background, educational career, and health</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Koivusilta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Lintonen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Rimpelä</surname></persName>
		</author>
		<idno type="DOI">10.1080/14034940600868721</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PxYsGFH">Scand J Public Health</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="95" to="103" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Koivusilta LK, Lintonen TP, Rimpelä AH. Orientations in adolescent use of information and communication technology: a digital divide by sociodemographic background, educational career, and health. Scand J Public Health. 2007;35(1):95-103.</note>
</biblStruct>

<biblStruct xml:id="b14">
	<monogr>
		<author>
			<persName><forename type="first">G</forename><surname>Goggin</surname></persName>
		</author>
		<title level="m" xml:id="_dAW2q88">Cell Phone Culture: Mobile Technology in Everyday Life</title>
		<meeting><address><addrLine>New York, NY</addrLine></address></meeting>
		<imprint>
			<publisher>Routledge</publisher>
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Goggin G. Cell Phone Culture: Mobile Technology in Everyday Life. New York, NY: Routledge; 2006.</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_xJbCgXT">Use of mobile phone text message reminders in health care services: a narrative literature review</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Kannisto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Koivunen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Välimäki</surname></persName>
		</author>
		<idno type="DOI">10.2196/jmir.3442</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_r5xNuNN">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page">222</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kannisto KA, Koivunen MH, Välimäki MA. Use of mobile phone text message reminders in health care services: a narrative literature review. J Med Internet Res. 2014;16(10):e222. doi:10.2196/jmir .3442.</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_2HdDud7">A quantitative systematic review of the efficacy of mobile phone interventions to improve medication adherence</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Howie-Esquivel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Dracup</surname></persName>
		</author>
		<idno type="DOI">10.1111/jan.12400</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pJTjBqG">J Adv Nurs</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1932" to="1953" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Park LG, Howie-Esquivel J, Dracup K. A quantitative systematic review of the efficacy of mobile phone interventions to improve medication adherence. J Adv Nurs. 2014;70(9):1932-1953.</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_D4JVSyU">A meta-analysis of the use of electronic reminders for patient adherence to medication in chronic disease care</title>
		<author>
			<persName><forename type="first">D</forename><surname>Tao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.1177/1357633x14541041</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KD3pfg6">J Telemed Telecare</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="3" to="13" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tao D, Xie L, Wang T, Wang T. A meta-analysis of the use of electronic reminders for patient adherence to medication in chronic disease care. J Telemed Telecare. 2015;21(1):3-13.</note>
</biblStruct>

<biblStruct xml:id="b18">
	<monogr>
		<title level="m" type="main" xml:id="_AvQPeA2">Cochrane Handbook for Systematic Reviews of Interventions</title>
		<author>
			<persName><forename type="first">Jpt</forename><surname>Higgins</surname></persName>
			<affiliation>
				<orgName type="collaboration">Cochrane Collaboration</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Green</surname></persName>
			<affiliation>
				<orgName type="collaboration">Cochrane Collaboration</orgName>
			</affiliation>
		</author>
		<idno type="DOI">10.1002/9780470712184</idno>
		<ptr target="http://www.cochrane-handbook.org" />
		<imprint>
			<date type="published" when="2011-03">March 2011. December 7, 2015</date>
		</imprint>
	</monogr>
	<note>Version 5.1.0</note>
	<note type="raw_reference">Cochrane Collaboration. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. http://www .cochrane-handbook.org. Updated March 2011. Accessed December 7, 2015.</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_sVwuT3j">Chapter 16.5.4: How to include multiple groups from one study</title>
		<author>
			<persName><forename type="first">Jpt</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Deeks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
		<idno type="DOI">10.1002/9780470712184.ch16</idno>
		<ptr target="http://www.cochrane-handbook.org" />
	</analytic>
	<monogr>
		<title level="m" xml:id="_F97EuXv">Cochrane Handbook for Systematic Reviews of Interventions</title>
		<editor>
			<persName><forename type="first">Jpt</forename><surname>Higgins</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">S</forename><surname>Green</surname></persName>
		</editor>
		<imprint>
			<date type="published" when="2011-03">March 2011. January 20, 2015</date>
		</imprint>
	</monogr>
	<note>Version 5.1.0</note>
	<note type="raw_reference">Higgins JPT, Deeks JJ, Altman DG. Chapter 16.5.4: How to include multiple groups from one study. In: Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. http://www.cochrane-handbook.org. Updated March 2011. Accessed January 20, 2015.</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_GgGcdmY">A mobile phone short message service improves perceived control of asthma: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Lv</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Liang</surname></persName>
		</author>
		<idno type="DOI">10.1089/tmj.2011.0218</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mPvZEPg">Telemed J E Health</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="420" to="426" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lv Y, Zhao H, Liang Z, et al. A mobile phone short message service improves perceived control of asthma: a randomized controlled trial. Telemed J E Health. 2012;18(6):420-426.</note>
</biblStruct>

<biblStruct xml:id="b21">
	<monogr>
		<title level="m" type="main" xml:id="_HmHZgB4">Comprehensive Meta-Analysis</title>
		<author>
			<persName><forename type="first">Mhl</forename><surname>Borenstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Rothstein</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2005">2005</date>
			<publisher>Biostat</publisher>
			<biblScope unit="volume">2</biblScope>
			<pubPlace>Englewood, NJ</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Borenstein MHL, Higgins J, Rothstein H. Comprehensive Meta-Analysis. Version 2. Englewood, NJ: Biostat; 2005.</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_kwpYyeK">Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Riley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Williamson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Whitehead</surname></persName>
		</author>
		<idno type="DOI">10.1177/1740774508100984</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DAGavh3">Clin Trials</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="16" to="27" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jones AP, Riley RD, Williamson PR, Whitehead A. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials. Clin Trials. 2009;6(1):16-27.</note>
</biblStruct>

<biblStruct xml:id="b23">
	<monogr>
		<title level="m" type="main" xml:id="_GVpxkMM">Statistical Power Analysis for the Behavioral Sciences</title>
		<author>
			<persName><forename type="first">J</forename><surname>Cohen</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1998">1998</date>
			<publisher>Lawrence Erlbaum Associates</publisher>
			<pubPlace>Hillsdale, NJ</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates; 1998.</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_E9N4UaF">Chapter 9.5: Heterogeneity</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Deeks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jpt</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
		<ptr target="http://www.cochrane-handbook.org" />
	</analytic>
	<monogr>
		<title level="m" xml:id="_9F3mYrt">Cochrane Handbook for Systematic Reviews of Interventions</title>
		<editor>
			<persName><forename type="first">Jpt</forename><surname>Higgins</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">S</forename><surname>Green</surname></persName>
		</editor>
		<imprint>
			<date type="published" when="2011-03">March 2011. January 20, 2015</date>
		</imprint>
	</monogr>
	<note>Version 5.1.0</note>
	<note type="raw_reference">Deeks JJ, Higgins JPT, Altman DG. Chapter 9.5: Heterogeneity. In: Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. http://www.cochrane-handbook.org. Updated March 2011. Accessed January 20, 2015.</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_wghW8eM">Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Duval</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Tweedie</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.0006-341x.2000.00455.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_tVWnq7q">Biometrics</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="455" to="463" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455-463.</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_AXSQDN2">Measuring, analyzing, and managing drug adherence in resistant hypertension</title>
		<author>
			<persName><forename type="first">M</forename><surname>Burnier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wuerzner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Struijker-Boudier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Urquhart</surname></persName>
		</author>
		<idno type="DOI">10.1161/hypertensionaha.113.00687</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_q9hZv8U">Hypertension</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="218" to="225" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Burnier M, Wuerzner G, Struijker-Boudier H, Urquhart J. Measuring, analyzing, and managing drug adherence in resistant hypertension. Hypertension. 2013;62(2):218-225.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
